Trademark Search  /  AMPLI1

AMPLI1

● Live · Registered

U.S. federal trademark · Serial No. 79310062 · Reg. No. 6617366

Mark
AMPLI1
Status
Registered
Serial Number
79310062
Registration No.
6617366
Filing Date
February 2, 2021
Registration Date
January 18, 2022
Class(es)
Class 001, Class 005

Owners

Menarini Silicon Biosystems S.p.A.
09 · IT
Menarini Silicon Biosystems S.p.A.
09 · IT
Menarini Silicon Biosystems S.p.A.
09 · IT

Goods & Services

Diagnostic kits composed of diagnostic agents, preparations and substances for medical use in disease testing; diagnostic preparations and materials, namely, diagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical purposes; clinical medical reagents; clinical diagnostic medical reagents; diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests for medical purposes; nucleic acid sequences for medical and veterinary purposes; reagents for in-vitro laboratory use being reagents for medical purposes

Chemical reagents for molecular biology not for medical or veterinary purposes; reagents for use in scientific apparatus for chemical analysis; reagents for scientific use; reagents for medical research use; genetic identity tests comprised of reagents for non-medical purposes; diagnostic kits comprising specimen receptors and reagents for testing for selected bacteria other than for medical or veterinary purposes; nucleic acid sequencing programs other than for medical and veterinary purposes; reagents for research purposes; laboratory reagents for scientific use; nucleic acid amplification reagents other than for medical and veterinary purposes; insemination result control diagnostic reagents for scientific use

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "AMPLI1" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.